$1.17+0.02 (+1.74%)
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China.
Park Ha Biological Technology Co., Ltd. in the Consumer Defensive sector is trading at $1.17 with a market capitalization of $4M. The stock is currently near its 52-week low of $0.93, remaining 85.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 23 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|
| Total Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | — | — | — | — |
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic sk...
Park Ha Biological has partnered with Star Plus Action to develop AI-driven skincare and wellness services, with the first product already launched and additional AI solutions planned across its retail and customer service network. Key Investor TakeawaysPark Ha Biological (NASDAQ:BYAH) is expanding beyond traditional skincare through an AI-powered skincare ecosystem partnership with Star Plus Action.
Park Ha announced a partnership with Star Plus Legend Group’s wholly-owned subsidiary, Star Plus Action, to jointly build a skincare and health ecosystem.
Elong Power Holding Ltd. 104,241,967 2.46